Syndromic X-linked Intellectual Disability Arts Type

Syndromic X-linked intellectual disability Arts type is a rare genetic disorder that mostly affects boys and causes serious problems with the brain and nerves from early infancy. Babies often have weak muscle tone (hypotonia), slow motor development, trouble with balance (ataxia), vision loss from optic nerve damage (optic atrophy), and sensorineural hearing loss. These problems happen because of harmful (“loss-of-function”) changes in a gene called PRPS1, which sits on the X chromosome and makes an enzyme (PRS-I) needed to build the body’s energy and genetic building blocks (purines and pyrimidines). When the enzyme is weak, cells—especially neurons and sensory cells—don’t get enough energy or nucleotides, so development and function suffer. Infections can be frequent and severe, and without early recognition and supportive care, the condition can be life-limiting. Cell+2NCBI+2

Arts syndrome is a very rare inherited condition that mainly affects boys and causes serious nervous-system problems that begin in early infancy. Typical features include weak muscle tone at birth (hypotonia), delayed motor milestones, difficulty with balance (ataxia), hearing loss, vision problems from optic-nerve damage (optic atrophy), frequent infections—especially chest infections—and intellectual disability. Girls who carry the gene change can be unaffected or have milder problems (often adult-onset hearing loss). The condition is X-linked, meaning the altered gene sits on the X chromosome and one changed copy can cause disease in males. Only a small number of families have been described worldwide. MedlinePlus+1

Arts syndrome is caused by loss-of-function mutations in the PRPS1 gene, which provides instructions for making phosphoribosyl-pyrophosphate synthetase-1 (PRPS-1). This enzyme makes PRPP, a key ingredient for building purine and pyrimidine nucleotides—the building blocks of DNA, RNA, and energy molecules such as ATP and GTP. When PRPS-1 activity is low, nucleotide supply falls, energy handling is stressed, and tissues that need lots of energy—especially the brain, nerves, and sensory organs—are most affected. This explains early hypotonia, developmental delay, neuropathy, hearing loss, and optic atrophy. MedlinePlus+1

PRPS1 changes can cause a spectrum of conditions: X-linked nonsyndromic deafness (DFN2), Charcot–Marie–Tooth disease type X5 (CMTX5) with neuropathy, Arts syndrome, and the opposite problem—PRPS1 superactivity, which leads to high uric acid and gout. Arts syndrome represents the severe, loss-of-function end of this spectrum. Recognizing the spectrum helps families and clinicians interpret genetic results and predict features. Nature+2Nature+2

Other names

• Ataxia–deafness–optic atrophy, lethal (ADOA-lethal)

• Lethal X-linked ataxia with deafness and optic atrophy

• Severe PRPS1 deficiency
  These alternate names reflect the most visible features (ataxia, hearing loss, optic atrophy) and the inheritance (X-linked). Wikipedia+2PMC+2

Arts syndrome is X-linked: typically boys are severely affected, while girls who carry the gene change may have no or milder symptoms. Females can occasionally show problems (for example, eye or hearing issues) due to skewed X-inactivation. MedlinePlus

Types

Doctors group Arts syndrome within a PRPS1-related spectrum—conditions that all involve the same gene but vary in severity. Think of it like a dimmer switch on the same pathway:

1. Arts syndrome (severe PRPS1 deficiency): early hypotonia, ataxia, severe hearing loss, optic atrophy, developmental delay/intellectual disability, infections. Cell

2. CMTX5 (X-linked Charcot-Marie-Tooth type 5): peripheral neuropathy with hearing loss and optic atrophy; usually later onset and milder than Arts. PMC

3. DFN2/DFNX1 (X-linked nonsyndromic sensorineural deafness): mainly prelingual deafness with little or no neurologic disability. NCBI

These sit on a continuum—different mutations can shift someone along this range, and even family members may vary. Nature

---

Causes

Because Arts syndrome is a genetic condition, “causes” here means the biological reasons/mechanisms that make symptoms happen or get worse.

1. PRPS1 gene loss-of-function mutations: The core cause; changes in PRPS1 reduce the PRS-I enzyme’s activity. Cell

2. Low PRPP production: The enzyme normally makes PRPP, a key “starter” molecule for purine/pyrimidine synthesis; reduced PRPP starves cells of nucleotides. MedlinePlus

3. Purine/pyrimidine shortage: Short supply of DNA/RNA building blocks disrupts brain and nerve development. MedlinePlus

4. Energy (ATP/GTP) shortfall: Less ATP/GTP hurts cells with high energy needs (like neurons, retina, cochlea). Nature

5. Optic nerve vulnerability: Optic nerve fibers rely on steady energy; shortage promotes optic atrophy and visual loss. Cell

6. Inner ear hair-cell stress: Sensory cells in the cochlea are highly energy-dependent, so hearing loss is common. Wiley Online Library

7. Peripheral nerve dysfunction: Nerves that control movement and sensation are affected, causing weakness/neuropathy. PMC

8. Cerebellar involvement: The balance center (cerebellum) struggles when nucleotide/energy supply is low, leading to ataxia. Cell

9. Immune system weakness: Some patients get frequent or severe infections, likely from reduced nucleotide pools in fast-dividing immune cells. Cell

10. Motor neuron/axonal stress: Long nerves are sensitive to metabolic deficits, worsening weakness and fatigue. PMC

11. Mitochondrial-nucleotide crosstalk: Limiting nucleotides can indirectly disturb mitochondrial function and neuronal survival. (Inference based on nucleotide deficiency in PRPS1 disorders.) Nature

12. Developmental timing: Damage starts in fetal/early infant life, so milestones are delayed from the beginning. Cell

13. Skewed X-inactivation in females: Some girls/women can show symptoms if most active X chromosomes carry the mutation. MedlinePlus

14. Variant position/effect: Different PRPS1 mutations disrupt the enzyme in different ways; more severe disruption → more severe disease. Nature

15. Protein structural instability: Certain mutations destabilize critical parts of PRS-I, reducing activity. BioMed Central

16. Reduced erythrocyte PRS activity: Measurable low enzyme activity is a biochemical hallmark tied to symptoms. Nature

17. Abnormal purine metabolites: Findings like low/absent urinary hypoxanthine signal suppressed purine turnover. NCBI

18. Relative low/low-normal serum uric acid: Unlike PRPS superactivity (gout), Arts patients often have low-normal uric acid, reflecting reduced purine production. NCBI

19. Overlap phenotypes: Some variants create “in-between” features (e.g., partial hearing loss or milder neuropathy), affecting the clinical picture. Nature

20. Environmental stressors (intercurrent infections): Illness places extra stress on already fragile metabolic pathways, worsening weakness or regression. (Observed clinically in severe cases.) Cell

---

Symptoms

1. Global developmental delay: Babies learn to roll, sit, or walk later because the brain and nerves lack energy and building blocks. Cell

2. Intellectual disability: Thinking, learning, and problem-solving are affected to varying degrees. Cell

3. Hypotonia (floppy muscles): Low muscle tone is often the first clue in infancy. Cell

4. Ataxia (poor balance/coordination): Children wobble or fall easily due to cerebellar and sensory nerve involvement. Cell

5. Peripheral neuropathy: Tingling, weakness, absent reflexes; more obvious in later infancy/childhood. PMC

6. Sensorineural hearing loss (often congenital, severe): Can be profound and picked up on newborn screening. Wiley Online Library

7. Optic atrophy & vision loss: Pale optic discs on eye exam; vision gradually declines. Cell

8. Nystagmus/visual tracking problems: Eye movements can be shaky from early infancy. Cell

9. Speech delay: Hearing loss + neurologic issues slow language development. Cell

10. Feeding difficulties/failure to thrive: Low tone and fatigue make feeding and weight gain hard. Cell

11. Frequent or severe infections: Recurrent respiratory or systemic infections are reported. Cell

12. Fatigue and exercise intolerance: Low cellular energy reduces stamina. Nature

13. Motor regression during illness: Skills can temporarily or permanently worsen after infections. Cell

14. Shortened lifespan in severe male cases: Historically many boys died young without targeted care. Cell

15. Milder, variable features in females: Some carriers show optic problems, hearing loss, or retinal disease. NCBI

---

Diagnostic tests

A) Physical exam

1. General pediatric/neurologic exam: Checks tone, reflexes, strength, sensation, and development; hypotonia and areflexia often appear early. Cell

2. Gait and balance assessment: Wide-based or unsteady gait suggests ataxia. Cell

3. ENT and hearing screen: Failed newborn screen or progressive hearing loss prompts genetic evaluation. Wiley Online Library

4. Ophthalmic exam (fundoscopy): Pale optic discs point to optic atrophy; retinal changes may be seen. NCBI

5. Infection history and growth checks: Recurrent infections and poor weight gain are red flags. Cell

B) Manual/bedside tests

6. Bedside hearing tests (otoacoustic emissions): Quick screen to confirm cochlear hair-cell function loss. Wiley Online Library

7. Visual acuity & color vision charts (age-appropriate): Track vision decline in optic atrophy. NCBI

8. Simple coordination tasks (finger-to-nose, heel-to-shin): Identify cerebellar ataxia. Cell

9. Tendon-reflex check: Reduced or absent reflexes support neuropathy. PMC

10. Bedside sensory testing (light touch/vibration): Distal sensory loss suggests axonal neuropathy. PMC

C) Lab & pathological tests

11. Genetic testing of PRPS1: Definitive test; sequencing finds the pathogenic variant. (Many labs and rare-disease networks offer PRPS1 testing.) Orpha+1

12. Erythrocyte PRS-I enzyme assay (where available): Shows reduced activity consistent with PRPS1 deficiency. Nature

13. Urinary purine analysis: Low/absent hypoxanthine supports reduced purine synthesis. NCBI

14. Serum uric acid: Often low-normal in Arts (helps distinguish from PRPS superactivity, which has high uric acid/gout). NCBI+1

15. Basic immune work-up (CBC, immunoglobulins): To evaluate infection susceptibility. (Clinical practice in reported cases.) Cell

16. Metabolic panel (lactate, liver/kidney tests): Baseline status and to guide supportive care; may be normal but helpful for monitoring. (Context from metabolic rare-disease care.) NCBI

D) Electrodiagnostic tests

17. Nerve conduction studies/EMG: Confirm peripheral neuropathy (reduced amplitudes/velocities). PMC

18. Electroretinography (ERG): Can show cone/rod dysfunction in those with retinal involvement. NCBI

E) Imaging tests

19. Brain MRI: May be normal or show cerebellar changes; supports evaluation of ataxia and excludes other causes. Cell

20. Ophthalmic imaging (OCT): Measures optic-nerve fiber layer thinning and retinal structure over time. (Reported within PRPS1-associated eye disease cohorts.) NCBI

Non-pharmacological treatments (therapies & other supports)

1. Early developmental intervention & special education. Enroll as soon as possible to support language, cognition, and daily skills. Purpose: maximize developmental potential. Mechanism: structured, repeated learning builds neural connections even when energy supply is lower. MedlinePlus

2. Physiotherapy. Gentle, regular exercises improve posture, balance, and strength to counter hypotonia and ataxia. Mechanism: neuroplasticity and muscle conditioning. MedlinePlus

3. Occupational therapy. Training for hand use, self-care, and adaptive equipment (grips, seating, utensils). Mechanism: task-oriented practice improves function and independence. MedlinePlus

4. Speech-language therapy & augmentative/alternative communication (AAC). Supports speech, comprehension, and alternative communication methods when speech is limited. Mechanism: targeted practice and visual/auditory supports. MedlinePlus

5. Hearing rehabilitation (hearing aids, auditory training; consider implant candidacy separately below). Purpose: maximize hearing to support learning and safety. Mechanism: amplification improves access to sound and language input. PMC

6. Low-vision and blindness services. Orientation/mobility training, high-contrast materials, and assistive tech compensate for optic atrophy. Mechanism: environmental adaptations reduce strain and improve safety. MedlinePlus

7. Respiratory physiotherapy & airway clearance. Chest physiotherapy, suction training, positioning to reduce pneumonia risk. Mechanism: improves mucus clearance and lung expansion. MedlinePlus

8. Nutritional support & safe feeding strategies. Swallow assessment, calorie-dense foods, and texture modifications to prevent aspiration and poor weight gain. Mechanism: matches swallowing ability to food texture; ensures energy intake. MedlinePlus

9. Infection-prevention routines. Hand hygiene, caregiver vaccination, crowd avoidance during outbreaks, early evaluation of cough/fever. Mechanism: lowers exposure and speeds treatment. MedlinePlus

10. Vision & hearing assistive technology. FM/DM systems, captioning, screen readers, braille displays. Mechanism: replaces or amplifies sensory input to support education and communication. MedlinePlus

11. Genetic counseling for family planning. Explains X-linked inheritance, carrier testing, and reproductive options. Mechanism: informed decisions reduce recurrence risk. NCBI

12. Care coordination & anticipatory guidance. Regular, multidisciplinary follow-up (neurology, audiology, ophthalmology, pulmonology, nutrition). Mechanism: proactive monitoring prevents avoidable complications. NCBI

13. Adaptive seating and mobility aids. Supports trunk control and safe mobility; reduces fatigue and falls. Mechanism: external support compensates for low tone and ataxia. MedlinePlus

14. Sleep optimization. Consistent routines and sleep hygiene; evaluate for sleep-disordered breathing if recurrent infections or hypotonia. Mechanism: restorative sleep supports cognition and immunity. MedlinePlus

15. Therapeutic recreation & safe physical activity. Low-impact play (water therapy, supported cycling) for fitness and socialization. Mechanism: improves endurance and mood without over-fatiguing. MedlinePlus

16. Communication-rich environment at home. Simplified language, gestures, picture schedules. Mechanism: increases successful interactions and reduces frustration. MedlinePlus

17. Home safety adaptations. Handrails, non-slip surfaces, clutter-free pathways to reduce falls in ataxia. Mechanism: environmental control minimizes risk. MedlinePlus

18. Psychosocial support for caregivers. Counseling, respite, and peer groups reduce stress and improve long-term care capacity. Mechanism: caregiver wellbeing improves child outcomes. MedlinePlus

19. Regular dental care. Hypotonia and feeding challenges can raise caries risk; adaptive toothbrushes and fluoride help. Mechanism: prevention reduces infection burden. MedlinePlus

20. School-based Individualized Education Plan (IEP). Legal accommodations (extra time, assistive tech, preferential seating). Mechanism: reduces access barriers to learning. MedlinePlus

Drug treatments

There is no curative drug for Arts syndrome. Medicines are used to treat symptoms, prevent complications, and—based on emerging data—support cellular metabolism. Dosing is always individualized by clinicians.

1. S-adenosyl-methionine (SAMe) (nutraceutical/“metabolic support”). Why: PRPS1 deficiency lowers nucleotide availability; SAMe may support methylation and nucleotide synthesis. Evidence: case reports/series show stabilization or improvement when SAMe is combined with nicotinamide riboside (NR). Typical use: oral daily; exact dose guided by specialists. Side effects: gastrointestinal upset, insomnia/anxiety in some. PMC+2PMC+2

2. Nicotinamide riboside (NR) (vitamin B3 form; NAD⁺ precursor). Why: boosts NAD⁺ pools and may enhance cellular energy. Evidence: co-therapy with SAMe improved T-cell survival/function and clinical symptoms in small reports. Use: oral; specialist-set dose. Side effects: flushing, nausea; long-term data limited. PMC+1

3. Broad-spectrum antibiotics for bacterial respiratory infections. Why: infections are common and can be life-threatening. Use: prompt, culture-guided therapy reduces complications. Risks: antibiotic-specific effects and resistance. MedlinePlus

4. Antipyretics/analgesics (e.g., acetaminophen/ibuprofen) during infections. Why: reduce fever and discomfort, improve hydration. Risks: drug-specific; dosing must be age/weight-appropriate. MedlinePlus

5. Bronchodilators and inhaled therapies when wheeze or mucus burden is present. Why: ease breathing; facilitate airway clearance. Risks: tachycardia or tremor (beta-agonists). MedlinePlus

6. Vaccines (routine schedule, including influenza and pneumococcal per local guidelines). Why: reduce infection risk that drives morbidity. Note: vaccines are preventive biologics managed by the care team. MedlinePlus

7. Prophylactic antibiotics (selected cases with recurrent, severe bacterial infections). Why: lower incidence of pneumonia/otitis; used cautiously to avoid resistance. MedlinePlus

8. Nutritional supplements when documented deficiency (e.g., iron, vitamin D). Why: correct specific deficits to support growth and immunity. Use: dose based on labs. MedlinePlus

9. Anti-seizure medicines if seizures occur (not universal). Why: control epileptic events to protect development and safety. Choice: individualized. MedlinePlus

10. Gastro-esophageal reflux therapy when reflux worsens feeding/aspiration (e.g., thickening strategies first; then medications as needed). Why: lowers aspiration risk and improves nutrition. MedlinePlus

11. Airway-clearance adjuncts (e.g., nebulized saline) as directed by pulmonology. Why: thin mucus to help clearance. MedlinePlus

12. Topical ocular lubricants for exposure or dryness. Why: protect cornea in low blink tone. MedlinePlus

13. Vitamin A (vision care) only if deficient—not a treatment for optic atrophy. Why: general ocular health; avoid hypervitaminosis. MedlinePlus

14. Sleep medicines (short-term, carefully) for significant sleep disruption after behavioral steps fail. Why: restore sleep to support immunity and learning. MedlinePlus

15. Spasticity medicines if tone abnormalities evolve (case-specific). Why: improve comfort and care. MedlinePlus

16. Constipation regimens (osmotic laxatives) when needed. Why: prevent discomfort and reduced intake. MedlinePlus

17. Antiemetics during acute illness (clinician-guided). Why: support hydration and medication tolerance. MedlinePlus

18. Probiotics (case-by-case) during antibiotics to reduce diarrhea (evidence variable). Why: microbiome support. MedlinePlus

19. Intravenous fluids/antibiotics during severe infections. Why: prevent respiratory failure/sepsis. MedlinePlus

20. Investigational metabolic support under specialist care (e.g., SAMe+NR protocols from case literature). Why: potential stabilization; still experimental. PMC+1

Important: The only pharmacologic approach with condition-specific evidence today is the investigational co-therapy of SAMe + NR, supported by case studies/series; larger trials are still needed. Families should discuss potential risks/benefits with a metabolic specialist. PMC+1

---

Dietary molecular supplements

There is no proven dietary cure. Any supplement should be clinician-guided, ensuring it doesn’t interact with medicines and is targeted to a documented need.

1. Nicotinamide riboside (NR): NAD⁺ precursor with small-study signals in Arts syndrome (co-therapy). Function: supports cellular energy. Mechanism: increases NAD⁺ for redox reactions. PMC+1

2. S-adenosyl-methionine (SAMe): methyl-donor supporting nucleotide cycles; used with NR in reports. Mechanism: feeds methylation-dependent steps linked to nucleotide metabolism. PMC

3. Standard multivitamin/mineral when intake is limited. Mechanism: corrects broad micronutrient gaps that can worsen fatigue/infections. MedlinePlus

4. Vitamin D (if low). Mechanism: bone and immune support. Use lab-guided dosing. MedlinePlus

5. Iron (only if iron-deficient). Mechanism: supports oxygen delivery/energy. Over-supplementation is harmful. MedlinePlus

6. High-calorie oral nutrition supplements (dietitian-planned). Mechanism: meets energy needs when feeding is slow/fatigable. MedlinePlus

7. Omega-3 fatty acids (general neuro-support; evidence not Arts-specific). Mechanism: membrane and anti-inflammatory effects. MedlinePlus

8. Probiotics during antibiotics to reduce diarrhea (strain-specific benefits). Mechanism: microbiome support. MedlinePlus

9. Electrolyte solutions during illness to maintain hydration. Mechanism: replaces losses and supports perfusion. MedlinePlus

10. Protein-energy fortification (oils, nut butters, powdered milk) if weight gain is poor. Mechanism: increases calorie density without large volume. MedlinePlus

---

Immunity booster / regenerative / stem-cell drugs

There are no proven immune-booster, regenerative, or stem-cell drugs for Arts syndrome, and such treatments are not recommended outside clinical trials. Current evidence supports good infection prevention, prompt treatment, and metabolic co-therapy (SAMe+NR) as investigational. If you see claims of cures, ask for peer-reviewed data and discuss with a metabolic specialist. PMC+2PMC+2

---

Procedures / surgeries

1. Cochlear implant (case-selection by audiology/ENT). What: electronic inner-ear device for severe sensorineural hearing loss. Why: improve sound perception and language access when hearing aids are insufficient. PMC

2. Gastrostomy tube (G-tube) when oral intake is unsafe or inadequate. What: feeding tube to the stomach. Why: secure nutrition/hydration and reduce aspiration risk. MedlinePlus

3. Tracheostomy or long-term airway support in exceptional cases with chronic aspiration or airway compromise. What: surgical airway. Why: improve ventilation and secretion management. MedlinePlus

4. Strabismus surgery if significant, symptomatic eye misalignment occurs (not for optic atrophy itself). Why: improves alignment and comfort/safety in selected patients. MedlinePlus

5. Orthopedic procedures (rare; case-specific) for severe deformities interfering with care or mobility. Why: improve function and comfort. MedlinePlus

---

Prevention & proactive care tips

1. Keep routine vaccinations up to date (including influenza per local schedule). Why: reduce infection risk that drives illness severity. MedlinePlus

2. Annual hearing & vision assessments. Why: adjust devices/strategies as needs change. PMC+1

3. Early treatment of cough/fever and low threshold for medical review. Why: infections can worsen quickly. MedlinePlus

4. Hand hygiene and crowd avoidance during outbreaks. Why: lowers exposure. MedlinePlus

5. Swallowing safety checks and texture adjustments. Why: prevent aspiration. MedlinePlus

6. Regular physiotherapy and safe activity. Why: preserve function and reduce falls. MedlinePlus

7. Nutrition monitoring with growth charts. Why: catch under-nutrition early. MedlinePlus

8. Care plans at school and emergency letters. Why: ensure rapid, appropriate responses. MedlinePlus

9. Genetic counseling for relatives. Why: clarify carrier status and options. NCBI

10. Multidisciplinary follow-up schedule. Why: proactive detection of new issues. NCBI

---

When to see a doctor (red flags)

Seek medical care urgently for breathing difficulty, fast/labored breathing, bluish lips, dehydration, high fever, persistent vomiting, seizures, sudden vision or hearing changes, unusual sleepiness, or any rapid deterioration. Children with Arts syndrome have a higher risk from chest infections, so early evaluation is essential. Schedule routine visits for development, hearing/vision checks, and to discuss genetic counseling and school supports. MedlinePlus+1

---

What to eat and what to avoid

Aim for a balanced, calorie-adequate diet with enough protein, complex carbohydrates, healthy fats, fruits/vegetables, and fluids. Use texture modifications (purees, soft solids, thickened liquids) if swallowing is unsafe, and consider calorie fortification when growth lags. There is no special “Arts syndrome diet,” and extreme or restrictive diets are not advised. Avoid choking hazards if coordination is poor; avoid excess added sugars and highly processed foods that displace nutrient-dense intake. Work with a dietitian to personalize a plan and adjust during illness. MedlinePlus

---

Frequently asked questions

1. Is Arts syndrome curable? No. Care focuses on prevention, rehabilitation, and supportive treatments; small studies suggest potential benefit from SAMe+NR as metabolic support, but more research is needed. PMC

2. How is it inherited? X-linked. Mothers who carry a PRPS1 change can pass it to children; boys are usually more affected. Carrier testing and counseling are recommended. MedlinePlus+1

3. What tests confirm it? Genetic testing of PRPS1 (panel/exome or targeted testing). NCBI

4. Why are infections so common? The exact reason is unclear; reduced cellular energy may impair immune responses. Prevention and early treatment matter. MedlinePlus

5. Do all girls with the variant get symptoms? No. Some have no symptoms; others—often adults—develop hearing loss or neuropathy. BioMed Central

6. Is hearing loss always present? It is common but not universal, and severity varies. PMC

7. Can cochlear implants help? Yes, in selected children with severe sensorineural loss after audiology/ENT assessment. PMC

8. Are there blood tests for the enzyme? Some centers assess pathways, but genetic testing is standard for diagnosis. NCBI

9. How common is Arts syndrome? Extremely rare; only a few families have been reported. MedlinePlus

10. Is it the same as PRPS1 superactivity? No. That is the opposite problem (too much enzyme activity) and causes gout/high uric acid. MedlinePlus

11. Can children attend school? Yes—with supports: hearing/vision devices, IEPs, therapy, and safety plans. MedlinePlus

12. Will symptoms get worse? Course varies; early therapy and infection prevention can improve quality of life. MedlinePlus

13. Are clinical trials available? Rare-disease trials are limited; ask a metabolic or genetics clinic to check registries. MedlinePlus

14. Should our family get genetic counseling? Yes. It explains risks, carrier testing, and reproductive options. NCBI

15. Where can we read more? GeneReviews and MedlinePlus Genetics offer clinician-vetted overviews; recent case reports discuss SAMe+NR therapy. NCBI+2MedlinePlus+2

Disclaimer: Each person’s journey is unique, treatment plan, life style, food habit, hormonal condition, immune system, chronic disease condition, geological location, weather and previous medical  history is also unique. So always seek the best advice from a qualified medical professional or health care provider before trying any treatments to ensure to find out the best plan for you. This guide is for general information and educational purposes only. Regular check-ups and awareness can help to manage and prevent complications associated with these diseases conditions. If you or someone are suffering from this disease condition bookmark this website or share with someone who might find it useful! Boost your knowledge and stay ahead in your health journey. We always try to ensure that the content is regularly updated to reflect the latest medical research and treatment options. Thank you for giving your valuable time to read the article.

The article is written by Team RxHarun and reviewed by the Rx Editorial Board Members

Last Updated: September 24, 2025.